Nikita A. Mironov

Nikita A. Mironov

Auto-generated profile, based on publicly available information

Nikita A. Mironov

Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2020 in Journal of microbiology, epidemiology and immunobiology
Verified
Journal Article
Open access
PDF file
IFIrina V. Feldblium
Irina V. Feldblium
КСКсения Андреевна Субботина
Ксения Андреевна Субботина
ОРОльга Александровна Рычкова
Ольга Александровна Рычкова
АМАлександр Николаевич Миронов
Александр Николаевич Миронов
ДВДарья Александровна Волкова
Дарья Александровна Волкова
ЯКЯрослава Юрьевна Кондратьева
Ярослава Юрьевна Кондратьева
Introduction. Rotavirus infection (RVI) is the most common cause of severe gastroenteritis in infants and young children worldwide: 600,000 children die annually; it accounts for approximately 3 million hospitalizations and 25 million physician visits each year among children. Preventive vaccination is universally recognized as the most effective measure against this infection.The purpose of the study is assessment of reactogenicity, safety and immunogenicity of the pentavalent live vaccine for RVI prevention in childhood immunization.Materials and methods. The first multicenter prospective, randomized, double-blind, placebo-controlled clinical trial of the pentavalent live vaccine for RVI prevention was conducted in Russia among healthy infants aged 2 months at the time of the first vaccination.Results. The vaccine had a satisfactory safety profile and high immunologic activity when administered in a threedose series for childhood immunization. No negative changes in the children’s health condition were detected during the surveillance monitoring.Discussion. The seroconversion rates, the seroconversion factor and the geometric mean antibody titer were consistent with the results obtained during trials of the above vaccine and its equivalents in other countries.

15 December 2021 in Journal of Modern Oncology
Verified
Journal Article
Open access
PDF file
PKPolina Klimovich
Polina Klimovich
KRKseniya A. Rubina
Kseniya A. Rubina
NMNikita A. Mironov
Nikita A. Mironov
VKViktor Kakotkin
Viktor Kakotkin
NONina A. Oleynikova
Nina A. Oleynikova
ESEkaterina Semina
Ekaterina Semina
Background. Lack of universal diagnostic parameters that can accurately and reliably diagnose presence of a malignant neoplasm, anticancer drug effectiveness or metastasis development including dormant ones and also to detect the progression or relapse of the disease at an early stage put on the first place studies related to the identification of such markers. Increased secretion and activity of the urokinase type plasminogen activator (uPA), its receptor (uPAR) accompany many types of malignant neoplasms, contributing their progression and metastasis, as well as the emergence of chemoresistance. So today these proteins are promising diagnostic targets in oncology. Aim. To evaluate the diagnostic significance of the expression levels of uPA and uPAR in blood serum of patients with colorectal and gastric adenocarcinoma and uPA/uPAR distribution in samples obtained from the primary tumor node, to assess the possibility of their use as universal diagnostic indicators in cancer patients at the stage of primary treatment. Materials and methods. The study included patients with colorectal and gastric adenocarcinoma in the amount of 50 people and 25 healthy volunteers. The content of uPA and uPAR in blood serum was assessed by enzyme-linked immunosorbent assay, the level of expression of the studied proteins in tumor tissue was assessed using immunohistochemical staining with antibodies to uPA and uPAR. Results. It was found that in comparison with healthy donors uPA serum concentration was significantly higher in all patients with adenocarcinoma, regardless of gender, and the uPAR content in the blood serum was significantly higher in women. Immunohistochemical staining data showed that the expression of these two proteins in tumor tissue significantly exceeds their expression in normal tissue. Conclusion. Based on the obtained data the possibility of using uPA in blood serum as a universal diagnostic criterion in patients with colorectal and gastric adenocarcinoma regardless of gender was shown and uPAR in female patients.

13 March 2024 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
NMN.A. Mironov
N.A. Mironov
APAlexander V Priezzhev
Alexander V Priezzhev
Anastasia SveshnikovaAnastasia Sveshnikova
Anastasia Sveshnikova
ALA.E. Lugovtsov
A.E. Lugovtsov
NKN.A. Karanadze
N.A. Karanadze
IOIana Orlova
Iana Orlova
The study protocol was developed by the staff of the Lomonosov Moscow State University. This study is devoted to the association between blood rheology, hemostasis and functional status in patients with chronic heart failure (CHF). The importance of this study is determined by the need for new approaches to diagnosis and treatment of elderly patients with cardiovascular diseases, especially in context of widespread CHF in population. The study focuses on non-cardiac causes of impaired tolerance to physical exertion and importance of blood in binding and delivering oxygen. A unique feature of this research is modern optical technologies and artificial intelligence. Diagnostic methods include measuring the microrheological blood parameters at the level of cells and blood samples using modern optical methods and digital image processing. The study aims to explore the role of erythrocytes as an indicator of cardiovascular health. The authors pay a particular attention to red cell distribution width as a quantitative measure of anisocytosis and a complex indicator associated with various pathological processes in chronic diseases. The authors will investigate deformability and aggregation of erythrocytes, as well as their adhesion to vascular endothelium that is crucial for adequate perfusion and oxygen delivery to peripheral tissues.

31 May 2025 in Medical academic journal
Verified
Journal Article
Closed access
PDF file
JKJulia Jessica D. Korobkina
Julia Jessica D. Korobkina
SGSofia V. Galkina
Sofia V. Galkina
ALAndrey Е. Lugovtsov
Andrey Е. Lugovtsov
NMNikita А. Mironov
Nikita А. Mironov
LDLarisa I. Dyachuk
Larisa I. Dyachuk
ЛЕЛуговцов Андрей Егорович
Луговцов Андрей Егорович
BACKGROUND: Cardiovascular diseases are the leading cause of mortality worldwide. Chronic heart failure is accompanied by hemodynamic disturbances, including alterations in blood microrheological properties. Changes in erythrocyte deformability may lead to impaired activation and interaction of platelets and neutrophils, contributing to thrombosis and the progression of chronic heart failure. AIM: Determination of neutrophil activity and thrombus formation in an ex vivo model of thromboinflammation in patients with chronic heart failure with simultaneous assessment of blood microrheology. METHODS: The study involved 21 patients with a diagnosis of chronic heart failure and 8 healthy volunteers. The patients and volunteers underwent determination of the biochemical composition of blood plasma and assessment of the condition of the blood elements. The thromboinflammation was evaluated in whole heparinized blood using parallel-flat flow chambers coated with type I collagen at a shear rate of 100 1/s. The deformability parameters of erythrocytes were measured in vitro using the method of laser diffractometry. Erythrocyte aggregation was determined by diffuse light scattering from whole blood samples. RESULTS: For thrombus areas, no statistical differences were found between healthy controls and patients with chronic heart failure. However, the neutrophil velocities for patients with chronic heart failure were significantly lower than for healthy controls (0.11 ± 0.02 µm/s for chronic heart failure versus 0.16 ± 0.04 µm/s for healthy controls). The thrombus areas for patients with chronic heart failure at 5 and 10 minutes of growth correlated with the concentration of red blood cells and the average volume of red blood cells. Also, the aggregation coefficients of erythrocytes A1 and A2 characterizing the intensity of the process of formation of linear and three-dimensional aggregates positively correlated with thrombus area. In addition, mean corpuscular volume, erythrocyte deformability indices, and yield strength of the erythrocytes correlated with neutrophil movement velocities. CONCLUSION: Thus, although there is no significant change in thrombus formation in chronic heart failure, however, we can talk about a decrease in neutrophil activity, possibly associated with the increase in blood viscosity.

21 February 2025 in Problems of Geroscience
Verified
Journal Article
Open access
PDF file
SZS. A. Zakharchuk
S. A. Zakharchuk
NMN. A. Mironov
N. A. Mironov
APA. G. Plisyuk
A. G. Plisyuk
IOIana Orlova
Iana Orlova
BACKGROUND. Global population aging leads to an increased rate of agerelated diseases such as arterial hypertension. Existing diagnostic methods are limited by the insufficient sensitivity of clinical and laboratory markers and the restrictions of conventional statistical methods. This highlights the need for new approaches to medical data analysis. This study is aimed to identify new laboratory markers of arterial hypertension using machine learning models and to compare their effectiveness compared with conventional methods. It involved the analysis of clinical and laboratory data of 2,228 patients over 65 years of age who sought medical advice at the clinic of the Medical Research and Educational Center of Lomonosov Moscow State University. Logistic regression with regularization, random forest, and gradient boosting were employed. Effectiveness was assessed using the AUC ROC, while attribute contributions were assessed by means of SHAP analysis. Machine learning models outperformed conventional logit regression. Gradient boosting achieved an AUC ROC of 0.85 compared to 0.78 for regression methods. The key attributes associated with arterial hypertension were age, RDW-SD value and creatinine levels, whereas conventional methods focused mainly on age. The conclusions confirm the high potential of machine learning methods in diagnosing age-related diseases. These models ensure higher accuracy and reveal complex interrelationships between indicators, which can improve early diagnosis and optimize diagnostic algorithms. Population aging is a global demographic trend leading to an increase in the incidence of agerelated diseases [1]. Early and accurate diagnosis of these conditions is becoming particularly important for effective treatment and minimization of the risk for complications in elderly patients. However, current diagnostic algorithms are often limited by the insufficient sensitivity and specificity of clinical and laboratory markers, while standard data analysis methods may not always detect hidden or nonlinear dependencies that are critical for diagnosis and prognosis assessment [2]. This necessitates the development of new approaches to interpretation of medical data and identification of more precise diagnostic criteria. Advances in machine learning (ML) and artificial intelligence (AI) offer new possibilities for the analysis of large and complex medical datasets. These methods allow uncovering complex and nonlinear relationships between various parameters, which can significantly enhance our understanding of pathogenesis, improve diagnostic accuracy, and increase the treatment effectiveness of age-related diseases in conditions of global population aging [3, 4].AIM. To identify new laboratory markers associated with arterial hypertension using ML models and to evaluate their effectiveness in comparison with conventional statistical methods.MATERIALS AND METHODS. A retrospective analysis was performed on a database containing clinical and laboratory indicators of 2,228 patients over 65 years of age who were affiliated with the Medical Research and Educational Center of Lomonosov Moscow State University and sought medical advice or underwent preventive examinations from 2020 to 2021. Data preprocessing included handling of missing values, dealing with outliers, and normalization of attributes. In this pilot study conducted to refine the analytical tools, the presence of arterial hypertension was considered the target variable. Binary logistic regression, a standard and widely accepted method for identification of disease markers, as well as ML models such as logistic regression with regularization, a random forest model, and gradient boosting were employed. The performance of these methods was assessed using the area under the ROC curve (AUC ROC). The contribution of each attribute was interpreted using the SHAP analysis.RESULTS. The ML models have been proven to be superior compared with conventional logistic regression. Gradient boosting achieved an AUC ROC of 0.85, whereas logistic regression showed an AUC ROC of 0.78 (Fig. 1). The most important attributes associated with the presence of arterial hypertension were age, red blood cell distribution width (RDW-SD), and creatinine levels. Meanwhile, the standard regression analysis relied primarily on age (Fig. 2, 3). Age and creatinine levels were expectedly significant factors, while RDW-SD, typically evaluated in the context of anemia and associated with erythropoiesis, was also identified as a significant marker of arterial hypertension. These findings may indicate a broader relationship between inflammatory processes and the state of erythropoiesis with the development of arterial hypertension.CONCLUSIONS. Our findings reveal the high potential of ML models in medical diagnostics for identification of new laboratory markers of age-related diseases. ML methods not only provide higher predictive accuracy but also uncover complex, previously unknown relationships between clinical and laboratory indicators and the onset and progression of diseases. Unlike conventional statistical methods, they account for nonlinear and multidimensional interactions between features. These findings can serve as a basis for further clinical research aimed at confirming the associations found and developing new targets for intervention, potentially leading to changes in diagnostic and treatment approaches. Implementation of these models in clinical practice may improve early diagnosis of age-related diseases, reduce morbidity and mortality, and ultimately enhance patient quality of life.

30 December 2025 in Russian Cardiology Bulletin
Verified
Journal Article
Closed access
PDF file
NMN.A. Mironov
N.A. Mironov
TKT.N. Krasnova
T.N. Krasnova
LDL.I. Dyachuk
L.I. Dyachuk
MUM.B. Usherzon
M.B. Usherzon
SZS.A. Zakharchuk
S.A. Zakharchuk
SMSimon Matskeplishvili
Simon Matskeplishvili
The clinical trial No. REFRANGINA-TRIAL protocol is aimed at dynamic assessment of myocardial perfusion and contractility in patients with refractory angina under combined intermittent hypo-hyperoxic therapy. Refractory angina characterized by persistent symptoms and impaired functional status despite optimal medical treatment, as well as ineffective invasive revascularization affects 5—10% of patients with coronary artery disease. The study will enroll 60 patients with coronary artery disease and refractory angina class II—III confirmed by stress tests. Patients will be randomized into three groups: group 1 — combined therapy (10 sessions of intermittent hypo-hyperoxic therapy over 2 weeks and 5-week medical therapy beginning 3 weeks prior to hypo-hyperoxic sessions); group 2 — a course of hypo-hyperoxic therapy with placebo (10 sessions over 2 weeks); group 3 — standard treatment according to current protocol. Treatment efficacy will be evaluated using contrast-enhanced perfusion MRI, echocardiography (with measurement of ejection fraction and global longitudinal strain of the left ventricle), stress tests (treadmill test and 6-minute walk test), as well as assessment of endothelial function by NICaS method and quality of life (SF-36 questionnaire). Treatment safety will be monitored through regular checks of vital signs, ECGs, laboratory tests, and physical examinations, along with recording of adverse events. The study is conducted in strict accordance with the Declaration of Helsinki, legislation of the Russian Federation, and Good Clinical Practice standards (ICH-GCP). It is anticipated that final results will confirm safety and efficacy of this new non-invasive approach for treating refractory angina. This will optimize therapeutic strategies and update clinical guidelines in the Russian Federation.